A markedly prolonged quinidine elimination half-life due to hepatic fa
ilure and resultant quinidine toxicity occurred in a 57-year-old man w
ith a history of atrial fibrillation. A prolonged QT interval, develop
ment of torsades de pointes, and a serum quinidine concentration of 3.
1 mu g/ml contributed to a decision favoring permanent pacemaker impla
ntation. The apparent quinidine half-life ranged from 66-99 hours and
was associated with QT prolongation and persistent U waves. On discont
inuing quinidine, all signs associated with toxicity resolved as serum
quinidine concentrations decreased, which resulted in reversal of the
decision to implant a permanent pacemaker. This case reports an extre
mely long quinidine elimination half-life and reillustrates the import
ance of drug pharmacokinetics in patient care.